# A Study to Identify and Characterize LAL-D Patients in High-risk Populations

> **NCT02345421** · — · TERMINATED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 640 (actual)

## Conditions studied

- Lysosomal Acid Lipase Deficiency

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02345421
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2016-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345421, "A Study to Identify and Characterize LAL-D Patients in High-risk Populations". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02345421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*